BWAY

Brainsway
BWAY

15.59 USD
0.00
0%
At close Updated Nov 7, 4:00 PM EST
1 day
0%
5 days
-11.97%
1 month
2.36%
3 months
31.78%
6 months
78.99%
Year to date
62.73%
1 year
47.91%
5 years
165.59%
10 years
40.58%
 

About: BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Employees: 120

Healthcare Medical Devices
0
Funds holding %
of 7,511 funds
Explore Fund Trends
0
Analysts bullish %
of 2 analysts
See Analyst Outlook
0
Positive news %
of 4 articles
Check Journalist POV
Price charts implemented using Lightweight Charts™